International Journal of Nanomedicine · 2018 · 42 citations · 21 references
PharmacyMolecular PharmaceuticsOncologyDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryCancer NanomedicineMagnetic Resonance Molecular ImagingMagnetic-responsive Drug DeliveryNanomaterials For Drug DeliveryNanomedicineTheranostic NanoparticlesAptamer-based Imaging AgentsHepatocellular Carcinoma ImagingIron Oxide NanoparticlesMagnetic Nanoparticle Drug DeliveryNanoparticle-based Contrast AgentsNanoparticle-based ProbesTargeted Molecular ProbesTumor-targeted Drug Delivery
Purpose: To construct and test a hepatocellular carcinoma (HCC)-targeted magnetic resonance probe based on a glypican-3 (GPC3)-specific aptamer (AP613-1) with ultrasmall superparamagnetic iron oxide (USPIO). Methods: Oleic acid-coated USPIO nanoparticles were modified with amino polyethylene glycol on the surface. Amino groups of the USPIO nanoparticles were reacted with the carboxyl group of 5' carboxyl-modified AP613-1, forming an aptamer-mediated USPIO (Apt-USPIO) probe. The material characterization of this probe including transmission electron microscopy (TEM), zeta potential, dynamic laser scattering, and magnetic behavior was carried out. The targeting efficiency and magnetic resonance imaging (MRI) performance of Apt-USPIO were evaluated both in vitro and in vivo with USPIO alone as a control. The cytotoxicity and biocompatibility of Apt-USPIO and USPIO were analyzed by cell counting kit-8 tests in vitro and animal experiments in vivo. Results: TEM imaging revealed that the Apt-USPIO nanoparticles were spherical in shape and well dispersed. Specific uptake of Apt-USPIO in Huh-7 cells could be observed using the Prussian blue staining test; however, no uptake of USPIO could be found. In vitro phantom T 2 -weighted MRI showed a significant decrease of the signal intensity in Apt-USPIO-incubated Huh-7 cells compared to USPIO-incubated Huh-7 cells. In vivo T 2 -weighted MRI showed significantly negative enhancement in the Huh-7 tumors enhanced with Apt-USPIO, whereas no enhancement was found with USPIO alone. Excellent biocompatibility of Apt-USPIO and USPIO was also demonstrated. Conclusion: In this study, a molecular MRI probe which was highly specific to GPC3 on HCC was successfully prepared. Our results validated the targeted imaging effect of this Apt-USPIO probe in vivo for GPC3-expressing HCCs in xenograft mice. Keywords: tumor-targeted imaging, carcinoma, hepatocellular, glypican-3, MRI, aptamer, ultrasmall superparamagnetic iron oxide
21
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
Mariana Capurro, Ian R. Wanless, Morris Sherman et al. · Gastroenterology · 2003 · 907 citations · Full text